Company Financials

Integral Diagnostics Limited Financials

Australian dollar

business Integral Diagnostics Limited Company Profile

Main Stock Listing

ASX: IDX

Market Capitalization A$628.7 Million as of July 1, 2024

Market Cap History

Valuations Metrics as of May. 5, 2024

Trailing PE 19.55
Forward PE 22.27
Price to Sales TTM A$1.26
Price to Book MRQ A$1.90
Enterprise to Revenue 2.01
Enterprise to EBITDA 12.89

Financial Reports as of Jun. 30, 2023

Financials

Fiscal Year Ends 2023-06-30
Most Recent Quarter 2023-06-30
Profit Margin -12.68%
Operating Margin 8.61%
Return on Assets TTM 3.34%
Return on Equity TTM -17.25%

Income Statement

Revenue TTM A$456,313,984
Revenue per Share TTM A$1.96
Quarterly Revenue Growth 7.20%
Gross Profit TTM A$419,059,000
EBITDA A$92,484,000
Net Income to Common TTM A$-57,853,000
Diluted EPS TTM A$-0.25
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ A$17,988,000
Total Cash per Share MRQ A$0.08
Total Debt MRQ A$
Total Debt to Equity MRQ 120.35
Current Ratio MRQ 0.76
Book Value per Share MRQ A$1.29

Cash Flow

Operating Cash Flow TTM A$62,043,000
Levered Free Cash Flow TTM A$6,789,500

IDX Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding 233,962,000
Float Shares 208,783,568
Avg 10 Volume 449,654
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 11.54%
% Held by Institutions 39.31%

Stock Price Summary

Beta 0.76
Fifty Two Week Low A$1.64
Fifty Two Week High A$3.54
Fifty Two Week Change -35.92%
Day 50 MA A$2.34
Day 200 MA A$2.37

Dividends and Splits

Forward Annual Dividend Rate A$0.10
Forward Annual Dividend Yield 4.08%
Trailing Annual Dividend Rate A$0.06
Trailing Annual Dividend Yield 2.45%
Payout Ratio 51.89%
Dividend Date
Ex Dividend Date 2024-02-29
Last Split Factor
Last Split Date